ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
As part of its Roadmap for Medical Research, NIH announced the establishment of the Chemical Genomics Center last week. The center is the first step of an initiative to set up a national network of centers that will produce chemical tools for use in biological research and drug development. The purpose of the center is to give "academic and government researchers a chance to contribute in a much more vigorous way to the earliest stages of the drug development pipeline: the identification of useful biological targets," explained National Human Genome Research Institute Director Francis S. Collins. In support of the research network, NIH plans to establish a repository to acquire, maintain, and distribute a collection of up to 1 million chemical compounds. To that end, the center plans to screen more than 100,000 small-molecule compounds in its first year. High-throughput screening is expected to begin later this year.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter